KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Repurchased
Ratios

GoodRx Holdings (GDRX) Accumulated Depreciation & Amortization (2019 - 2024)

Historic Accumulated Depreciation & Amortization for GoodRx Holdings (GDRX) over the last 6 years, with Q4 2024 value amounting to $18.2 million.

  • GoodRx Holdings' Accumulated Depreciation & Amortization rose 3223.56% to $18.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $18.2 million, marking a year-over-year increase of 3223.56%. This contributed to the annual value of $18.2 million for FY2024, which is 3223.56% up from last year.
  • Latest data reveals that GoodRx Holdings reported Accumulated Depreciation & Amortization of $18.2 million as of Q4 2024, which was up 3223.56% from $13.8 million recorded in Q4 2023.
  • In the past 5 years, GoodRx Holdings' Accumulated Depreciation & Amortization ranged from a high of $18.2 million in Q4 2024 and a low of $2.1 million during Q4 2020
  • Over the past 5 years, GoodRx Holdings' median Accumulated Depreciation & Amortization value was $9.8 million (recorded in 2022), while the average stood at $9.9 million.
  • Per our database at Business Quant, GoodRx Holdings' Accumulated Depreciation & Amortization surged by 17366.2% in 2021 and then surged by 3223.56% in 2024.
  • Quarter analysis of 5 years shows GoodRx Holdings' Accumulated Depreciation & Amortization stood at $2.1 million in 2020, then skyrocketed by 173.66% to $5.8 million in 2021, then surged by 67.59% to $9.8 million in 2022, then surged by 41.12% to $13.8 million in 2023, then surged by 32.24% to $18.2 million in 2024.
  • Its last three reported values are $18.2 million in Q4 2024, $13.8 million for Q4 2023, and $9.8 million during Q4 2022.